Page 96 - JCTR-11-4
P. 96

Journal of Clinical and
            Translational Research                                       NADPH oxidase inhibition in a rodent stroke model



            Availability of data                                  acute stroke. Ann Neurol. 2006;59(3):467-477.

            Data will be made available upon request to the       doi: 10.1002/ana.20741
            corresponding author.                              11.  Dirnagl U. Bench to bedside: The quest for quality in
                                                                  experimental stroke research.  J  Cereb  Blood  Flow  Metab.
            References                                            2006;26(12):1465-1478.
            1.   Institute  for Health  Metrics  and Evaluation (IHME).      doi: 10.1038/sj.jcbfm.9600298
               Global  Burden  of Disease  2021:  Findings  from  the  GBD   12.  Fabian RH, Perez-Polo JR, Kent TA. Perivascular nitric oxide
               2021 Study. Seattle, WA: IHME; 2024. Available from:   and superoxide in neonatal cerebral hypoxia-ischaemia. Am
               https://www.healthdata.org/sites/default/files/2024-05/  J Physiol Heart Circ Physiol. 2008;295(4):H1809-H1814.
               gbd_2021_booklet_final_2024.05.16.pdf [Last accessed on
               2024 Apr 01].                                      doi: 10.1152/ajpheart.00301.2007
            2.   Saini V, Guada L, Yavagal DR. Global epidemiology of   13.  Allan  SM,  Rothwell  NJ.  Cytokines  and  acute
               stroke and access to acute ischaemic stroke interventions.   neurodegeneration. Nat Rev Neurosci. 2001;2(10):734-744.
               Neurology. 2021;97(20 Suppl 2):S6-S16.
                                                                  doi: 10.1038/35094583
               doi: 10.1212/WNL.0000000000012781
                                                               14.  Doyle KP, Simon RP, Stenzel-Poore MP. Mechanisms
            3.   Hisham NF, Bayraktutan U. Epidemiology, pathophysiology,   of  ischaemic  brain  damage.  Neuropharmacology.
               and treatment of hypertension in ischaemic stroke patients.   2008;55(3):310-318.
               J Stroke Cerebrovasc Dis. 2013;22(7):e4-14.
                                                                  doi: 10.1016/j.neuropharm.2008.01.005
               doi: 10.1016/j.jstrokecerebrovasdis.2012.05.001
                                                               15.  Bayraktutan  U.  Endothelial  progenitor  cells:  Potential
            4.   Feigin VL, Brainin M, Norrving B,  et al. World Stroke   novel  therapeutics  for  ischaemic  stroke.  Pharmacol Res.
               Organization:  Global  stroke  fact  sheet  2025.  Int J Stroke.   2019;144:181-191.
               2025;20(2):132-144.
                                                                  doi: 10.1016/j.phrs.2019.04.017
               doi: 10.1177/17474930241308142
                                                               16.  Proctor  PH,  Tamborello  LP.  SAINT-I  worked,  but  the
            5.   Feigin VL, Stark BA, Johnson CO, et al. Global, regional, and   neuroprotectant is not NXY-059. Stroke. 2007;38(10):e109;
               national burden of stroke and its risk factors, 1990-2019:   author reply e110.
               A systematic analysis for the Global Burden of Disease Study      doi: 10.1161/STROKEAHA.107.489161
               2019. Lancet Neurol. 2021;20(10):795-820.
                                                               17.  Shuaib A, Lees KR, Lyden P,  et al. NXY-059 for the
               doi: 10.1016/S1474-4422(21)00252-0
                                                                  treatment of  acute  ischaemic stroke.  N  Engl J Med.
            6.   Allen CL, Bayraktutan U. Oxidative stress and its role   2007;357(6):562-571.
               in the pathogenesis of ischaemic stroke.  Int J Stroke.      doi: 10.1056/NEJMoa070240
               2009;4(6):461-470.
                                                               18.  Cifuentes-Pagano E, Csanyi G, Pagano PJ. NADPH oxidase
               doi: 10.1111/j.1747-4949.2009.00387.x
                                                                  inhibitors: A decade of discovery from Nox2ds to HTS. Cell
            7.   McMeekin P, Flynn D, James M, Price CI, Ford GA, White   Mol Life Sci. 2012;69(14):2315-2325.
               P. Updating estimates of the number of UK stroke patients      doi: 10.1007/s00018-012-1009-2
               eligible for endovascular thrombectomy: Incorporating
               recent evidence to facilitate service planning. Eur Stroke J.   19.  Gorlach A, Brandes RP, Bassus S, et al. Oxidative stress and
               2021;6(4):349-356. doi:10.1177/23969873211059471   expression of p22phox are involved in the up-regulation of
                                                                  tissue factor in vascular smooth muscle cells in response to
            8.   Martins SCO, Pontes-Neto OM, Pille A, et al. Reperfusion
               therapy for acute ischaemic stroke: Where are we in 2023?   activated platelets. FASEB J. 2000;14(11):1518-1528.
               Arq Neuropsiquiatr. 2023;81(12):1030-1039.      20.  Lassegue B, Griendling KK. NADPH oxidases: Functions
                                                                  and pathologies in the vasculature. Arterioscler Thromb Vasc
               doi: 10.1055/s-0043-1777721
                                                                  Biol. 2010;30(4):653-661.
            9.   Hacke W,  Furlan AJ, Al-Rawi Y.  et al. Intravenous
               desmoteplase in patients with acute ischaemic stroke selected      doi: 10.1161/ATVBAHA.108.181610
               by MRI perfusion-diffusion weighted imaging or perfusion   21.  Suh SW, Shin BS, Ma H, et al. Glucose and NADPH oxidase
               CT (DIAS-2): A  prospective, randomised, double-blind,   drive neuronal superoxide formation in stroke. Ann Neurol.
               placebo-controlled study. Lancet Neurol. 2009;8(2):141-150.  2008;64(6):654-663.
               doi: 10.1016/S1474-4422(08)70267-9                 doi: 10.1002/ana.21511
            10.  O’Collins VE, Macleod MR, Donnan GA, Horky LL, van der   22.  Abramov AY, Scorziello A, Duchen MR. Three distinct
               Worp BH, Howells DW. 1,026 experimental treatments in   mechanisms generate oxygen free radicals in neurons and


            Volume 11 Issue 4 (2025)                        90                            doi: 10.36922/jctr.25.00018
   91   92   93   94   95   96   97   98   99   100   101